Initial experiences with novel therapy for pulmonary hypertension in Slovakia.
Pulmonary hypertension (PH) is the most serious and potentially devastating chronic disorder of the pulmonary circulation with diverse etiologies and pathogenesis characterized by abnormal increased vasoconstriction and vascular remodelling. Current specific therapy of PH is based on an understanding of its pathogenesis and is acting through pathogenic pathways and therefore changes therapeutic strategy, effectively improves clinical course and prolongs life. The authors discuss the actual classification, pathogenesis in short and particularly actual treatment modalities and the impact on the natural history of this disorder. In chronic thromboembolic pulmonary hypertension is pulmonary endarterectomy if correct indicated the curable method, warranted substantial improvement of life quality and survival. These novel therapies of PH were absent in Slovakia until recently. The authors present initial experiences, results of PH management up to date on the basis of cooperation with PH centres in Austria and Czech Republic (Tab. 1, Fig. 6, Ref. 32).
Simkova
I
I
Department of Cardiology, National Institute of Cardiovascular Diseases, Slovak Medical University, Bratislava, Slovakia. simkova@susch.sk
Pacak
J
J
Riecansky
I
I
Vulev
I
I
Jansa
P
P
Aschermann
M
M
Lang
I
I
Klepetko
W
W
D000328:Adult; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000628:therapy*; D008297:Male; D008875:Middle Aged